Utilizing Computational Machine Learning Tools to Understand Immunogenic Breadth in the Context of a CD8 T-Cell Mediated HIV Response.

Journal: Frontiers in immunology
PMID:

Abstract

Predictive models are becoming more and more commonplace as tools for candidate antigen discovery to meet the challenges of enabling epitope mapping of cohorts with diverse HLA properties. Here we build on the concept of using two key parameters, diversity metric of the HLA profile of individuals within a population and consideration of sequence diversity in the context of an individual's CD8 T-cell immune repertoire to assess the HIV proteome for defined regions of immunogenicity. Using this approach, analysis of HLA adaptation and functional immunogenicity data enabled the identification of regions within the proteome that offer significant conservation, HLA recognition within a population, low prevalence of HLA adaptation and demonstrated immunogenicity. We believe this unique and novel approach to vaccine design as a supplement to vitro functional assays, offers a bespoke pipeline for expedited and rational CD8 T-cell vaccine design for HIV and potentially other pathogens with the potential for both global and local coverage.

Authors

  • Ed McGowan
    IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom.
  • Rachel Rosenthal
    Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, United Kingdom.
  • Andrew Fiore-Gartland
    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
  • Gladys Macharia
    IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom.
  • Sheila Balinda
    Medical Research Council/Uganda Virus Research Institute (MRC/UVRI) and London School of Health and Tropical Medicine (LSHTM), Uganda Research Unit, Entebbe, Uganda.
  • Anne Kapaata
    Medical Research Council/Uganda Virus Research Institute (MRC/UVRI) and London School of Health and Tropical Medicine (LSHTM), Uganda Research Unit, Entebbe, Uganda.
  • Gisele Umviligihozo
    Project San Francisco (PSF) Center for Family Health Research (CFHR), Kigali, Rwanda.
  • Erick Muok
    Project San Francisco (PSF) Center for Family Health Research (CFHR), Kigali, Rwanda.
  • Jama Dalel
    IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom.
  • Claire L Streatfield
    IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom.
  • Helen Coutinho
    IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom.
  • Dario Dilernia
    Emory Vaccine Center, Emory University, Atlanta, GA, United States.
  • Daniela C Monaco
    Emory Vaccine Center, Emory University, Atlanta, GA, United States.
  • David Morrison
    Bitefirst, South Walsham, United Kingdom.
  • Ling Yue
    Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Eric Hunter
    Emory Vaccine Center, Emory University, Atlanta, GA, United States.
  • Morten Nielsen
    Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
  • Jill Gilmour
    IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom.
  • Jonathan Hare
    Biolife Research Limited, Nairobi, Kenya.